Toward a unified biosignature for tuberculosis

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 1, 2015, Pages

  Maertzdorf, Jeroen ^a   Kaufmann, Stefan H E ^a   Weiner, January ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENETIC MARKER;

ARTICLE; BIOINFORMATICS; CLASSIFICATION ALGORITHM; DISEASE CLASSIFICATION; GENE EXPRESSION; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; IMMUNE RESPONSE; K NEAREST NEIGHBOR; MACHINE LEARNING; METABOLOMICS; NONHUMAN; PREDICTIVE VALIDITY; PREDICTIVE VALUE; PROGNOSIS; RANDOM FOREST; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; TRANSCRIPTOMICS; TUBERCULOSIS; ALGORITHM; ARTIFICIAL INTELLIGENCE; BIOASSAY; GENE EXPRESSION PROFILING; GENETIC MARKER; METABOLISM; PHYSIOLOGY; PROCEDURES;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84923792082     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a018531     Document Type: Article

References (40)

1. Al-Zamel FA. 2009. Detection and diagnosis of Mycobacterium tuberculosis. Expert Rev Anti Infect Ther 7: 1099-1108.
2. Ballanti E, Perricone C, Greco E, Ballanti M, Di MG, Chimenti MS, Perricone R. 2013. Complement and autoimmunity. Immunol Res 56: 477-491.
3. Barry CE III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ, Young D. 2009. The spectrum of latent tuberculosis: Rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845-855.
4. Barth RE, Mudrikova T, Hoepelman AI. 2008. Interferon-g release assays (IGRAs) in high-endemic settings: Could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting. Int J Infect Dis 12: e1-e6.
5. Bekmurzayeva A, Sypabekova M, Kanayeva D. 2013. Tuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb) 93: 381-388.
6. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
7. Bloom CI, Graham CM, Berry MP, Wilkinson KA, Oni T, Rozakeas F, Xu Z, Rossello-Urgell J, Chaussabel D, Banchereau J, et al. 2012. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS ONE 7: e46191.
8. Bloom CI, Graham CM, Berry MP, Rozakeas F, Redford PS, Wang Y, Xu Z, Wilkinson KA, Wilkinson RJ, Kendrick Y, et al. 2013. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLoS ONE 8: e70630.
9. Cliff JM, Lee JS, Constantinou N, Cho JE, Clark TG, Ronacher K, King EC, Lukey PT, Duncan K, van Helden PD, et al. 2013. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 207: 18-29.
10. Davies PD, Pai M. 2008. The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis 12: 1226-1234.
11. Diaz-Uriarte R, Alvarez de AS. 2006. Gene selection and classification of microarray data using random forest. BMC Bioinformatics 7: 3.
12. Harries AD, Maher D, Nunn P. 1998. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World Health Organ 76: 651-662.
13. Ho JW, Stefani M, dos Remedios CG, Charleston MA. 2008. Differential variability analysis of gene expression and its application to human diseases. Bioinformatics 24: i390-i398.
14. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ, Kaufmann SH, Ziegler A. 2006. Deconfounding microarray analysis-Independent measurements of cell type proportions used in a regression model to resolve tissue heterogeneity bias. Methods Inf Med 45: 557-563.
15. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ, Ziegler A, Kaufmann SH. 2007. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 85: 613-621.
16. Jacobsen M, Repsilber D, Kleinsteuber K, Gutschmidt A, Schommer-Leitner S, Black G, Walzl G, Kaufmann SH. 2011. Suppressor of cytokine signaling-3 is affected in T- cells from tuberculosis TB patients. Clin Microbiol Infect 17: 1323-1331.
17. Joosten SA, Goeman JJ, Sutherland JS, Opmeer L, de Boer KG, Jacobsen M, Kaufmann SH, Finos L, Magis-Escurra C, Ota MO, et al. 2012. Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun 13: 71-82.
18. Joosten SA, Fletcher HA, Ottenhoff TH. 2013. A helicopter perspective on TB biomarkers: Pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS ONE 8: e73230.
19. Kaforou M, Wright VJ, Oni T, French N, Andersen ST, Bangani N, Banwell CM, Brent AJ, Crampin AC, Dockrell HM, et al. 2013. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: A case-control study. PLoS Med 10: e1001538.
20. Koth LL, Solberg OD, Peng JC, Bhakta NR, Nguyen CP, Woodruff PG. 2011. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med 184: 1153-1163.
21. Lesho E, Forestiero FJ, Hirata MH, Hirata RD, Cecon L, Melo FF, Paik SH, Murata Y, Ferguson EW, Wang Z, et al. 2011. Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis (Edinb) 91: 390-399.
22. Lin PL, Flynn JL. 2010. Understanding latent tuberculosis: A moving target. J Immunol 185: 15-22.
23. Lin PL, Ford CB, Coleman MT, Myers AJ, Gawande R, Ioerger T, Sacchettini J, Fortune SM, Flynn JL. 2014. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med 20: 75-79.
24. Maertzdorf J, Ota M, Repsilber D, Mollenkopf HJ, Weiner J, Hill PC, Kaufmann SH. 2011a. Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS ONE 6: e26938.
25. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, Walzl G, Kaufmann SH. 2011b. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15-22.
26. Maertzdorf J, Weiner J III, Kaufmann SH. 2012a. Enabling biomarkers for tuberculosis control. Int J Tuberc Lung Dis 16: 1140-1148.
27. Maertzdorf J, Weiner J, Mollenkopf HJ, Bauer T, Prasse A, Muller-Quernheim J, Kaufmann SH. 2012b. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci 109: 7853-7858.
28. Mahomed H, Ehrlich R, Hawkridge T, Hatherill M, Geiter L, Kafaar F, Abrahams DA, Mulenga H, Tameris M, Geldenhuys H, et al. 2013. TB incidence in an adolescent cohort in South Africa. PLoS ONE 8: e59652.
29. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, Reves RR, Toney SR, Daniels LJ, LoBue PA. 2007. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-g release assays in persons with suspected tuberculosis. Clin Infect Dis 45: 837-845.
30. Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, Wilson PA, Dockrell HM, Wallace DM, van Helden PD, Duncan K, et al. 2007. Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 195: 357-365.
31. Norbis L, Miotto P, Alagna R, Cirillo DM. 2013. Tuberculosis: Lights and shadows in the current diagnostic landscape. New Microbiol 36: 111-120.
32. Normand R, Yanai I. 2013. An introduction to high- throughput sequencing experiments: Design and bioinformatics analysis. Methods Mol Biol 1038: 1-26.
33. Ottenhoff TH, Dass RH, Yang N, Zhang MM, Wong HE, Sahiratmadja E, Khor CC, Alisjahbana B, van CR, Marzuki S, et al. 2012. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS ONE 7: e45839.
34. Pritchard CC, Hsu L, Delrow J, Nelson PS. 2001. Project normal: Defining normal variance in mouse gene expression. Proc Natl Acad Sci 98: 13266-13271.
35. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N. 2013. Xpertw MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1: CD009593.
36. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. 2011. Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
37. Walzl G, Haks MC, Joosten SA, Kleynhans L, Ronacher K, Ottenhoff THM. 2014. Clinical immunology and multiplex biomarkers of human tuberculosis. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a018515.
38. Weiner J III, Parida SK, Maertzdorf J, Black GF, Repsilber D, Telaar A, Mohney RP, Arndt-Sullivan C, Ganoza CA, Fae KC, et al. 2012. Biomarkers of inflammation, immuno- suppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients. PLoS ONE 7: e40221.
39. Weiner J, Maertzdorf J, Kaufmann SH. 2013. The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis. Ann NY Acad Sci 1283: 22-29.
40. Welsh KJ, Lewis CT, Boyd S, Braun MC, Actor JK. 2012. Complement factor C7 contributes to lung immunopathology caused by Mycobacterium tuberculosis. Clin Dev Immunol 2012: 429675.